Johnson & Johnson wins lawsuit over talc-related cancer claims

Saturday 06 June 2026 - 08:45

Johnson & Johnson has secured a legal victory in a high-profile lawsuit involving allegations that its talc-based products caused ovarian cancer. A jury in Los Angeles ruled in favor of the healthcare giant, concluding that the company was not negligent in the marketing and sale of its cosmetic talc products.

The case was brought by the families of three women who developed ovarian cancer after years of using talc-based baby powder. The plaintiffs argued that prolonged exposure to the products contributed to the disease and that consumers were not adequately warned about potential risks.

The verdict represents another chapter in a long-running legal battle that has involved tens of thousands of claims against the company. Over the years, Johnson & Johnson has faced lawsuits from individuals who alleged that certain talc products were linked to serious health conditions, including ovarian cancer and other illnesses.

The company has consistently denied that its talc products are unsafe, maintaining that extensive scientific research supports their safety when used as intended. Company representatives welcomed the jury's decision, arguing that the evidence presented during the trial supported their position.

At the same time, attorneys representing the plaintiffs expressed disappointment with the outcome and reiterated their belief that consumers deserve greater transparency regarding product safety concerns.

The legal debate surrounding talc products has attracted significant attention from health experts, regulators and consumer advocacy groups. Scientific studies examining the possible relationship between talc use and ovarian cancer have produced varying conclusions over the years, contributing to ongoing discussions within both the medical and legal communities.

In response to public concerns and continued litigation, Johnson & Johnson previously discontinued the sale of talc-based baby powder in the United States and transitioned to alternative formulations made from cornstarch. The company stated that the decision was driven by changing consumer preferences and market dynamics rather than product safety issues.

Despite recent courtroom victories, legal proceedings involving talc products continue in several jurisdictions. The broader controversy remains one of the most closely watched corporate and public health disputes in the United States.